(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including,e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

Saved in:
Bibliographic Details
Main Authors Estiarte Martinez, Maria de los Àngeles, Valls Vidal, Nuria, Fyfe, Matthew Colin Thor, Castro Palomino Laria, Julio Cesar, Kurz, Guido, Ortega Muñoz, Alberto, Martinell Pedemonte, Marc
Format Patent
LanguageEnglish
Published 25.06.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including,e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
Bibliography:Application Number: US201815911535